Journal of Neurology and Neurological Disorders

Dr. Shady Samy is a Neurology specialist with a particular interest and experience in stroke medicine, interventional Neurology, epilepsy, Multiple sclerosis, dementia, movement disorders, and neuro-muscular diseases. Before his joining Burjeel Medical Centre, he served for ten +years as a resident, then assistant lecturer, then lecturer of neurology and stroke medicine at the busy Ain Shams University hospitals, which is considered one of the largest tertiary centers in Egypt, getting exposed to complicated cases, treatment decisions, and various responses. He also gained experience working at the Saudi German- Cairo branch doing a great job at managing emergency, clinic, and outpatient neurological patients. Dr. Shady Samy has also finished his training as a fellow of stroke medicine and interventional Neurology and served as a primary operator for many brain stroke and Hemorrhage cases for diagnostic and therapeutic interventions. In addition to that, Dr. Shady has been exposed to complicated issues of adult and pediatric epilepsy, being a part of the pre-surgical planning team and also a part of pediatric and adult neuro-rehab team, being familiar with Botox injections, rTMS, and targeted physiotherapy and surgical interventions for spasticity. Dr. Shady completed his MBBCh from Ain Shams University, Egypt, in 2010, then his Master’s Degree and MD (Ph.D.) in Neurology from the same university in 2014,2020, respectively. He has also been working as a visiting physician at the Springfield memorial hospital, the University of Louisville in the USA, St George’s university hospital in the UK, and P.Stadins clinical university hospital in Latvia. His areas of expertise include,

Research: Stroke Medicine, Interventional Neurology, Epilepsy ( Adult, Pediatric, and Drug-Resistant), Headache and Neuralgias, Multiple Sclerosis and Other Demyelinating Disorders, Dementia, Movement Disorders, Neuro-muscular Disorders, Pediatric Neurology, Neuro-rehab and Spasticity, Pain Disorders

Dr. Yanying Liu, Ph.D., is a Professor and Academic Leader in the Department of Basic Medicine at Qingdao Huanghai University, China. She has an extensive academic and research background with expertise in neuroscience and neurodegenerative diseases. Dr. Liu obtained her Ph.D. from the Institute of Biophysics, Chinese Academy of Sciences, following her earlier studies at Capital Medical University in Beijing. She has held several international research and academic positions, including at the National University of Singapore, SUNY Upstate Medical University (USA), and the University of South Dakota (USA). Dr. Liu’s research primarily focuses on the molecular and cellular mechanisms underlying stroke, Alzheimer’s disease, aging, brain hypoxia injury, and stem cell biology. Her work aims to advance the understanding of neurological disorders and contribute to the development of innovative therapeutic strategies for brain injury and neurodegeneration.

Research: Stroke; Alzheimer’s disease; Aging; Brain hypoxia injury; Stem cells

Professor Rashmi Bansal is currently working as a professor in the Department of Neuroscience at the University of Connecticut Health Center, Farmington, United States. She received Ph. D in neuroscience from Central Drug Research Institute, Lucknow, India in 1976.  She has Research Grant Support to her research works from NIH. Rashmi Bansal Received JAVITS AWARD with the continuation of funding till 6/30/20. She has published more than 60 peer review articles. She was a committee member in several neurology societies from 1995-2014. She was an organiser in so many Scientific Meetings which was conducted in Germany, Thailand, Korea, India, Mexico, etc. She serves as an editorial board member for several journals.

Research: Molecular Mechanisms of Regulation of Myelination Cellular and Molecular Biology of Oligodendrocytes Fibroblast Growth Factor Receptors Transgenic Mouse Models Transfection Systems Central Nervous System Neurodegenerative Diseases Multiple Sclerosis Cell Culture Growth Factor

J. Vernon Odom, Ph.D. is Professor of Ophthalmology, Professor of Physiology and Pharmacology, and Adjunct Professor of Psychology at West Virginia University where he heads the West Virginia Lions Visual Function Laboratory. He received his Ph.D. in Psychology from the University of North Carolina at Greensboro, in 1978. He completed his undergraduate education at Davidson College in North Carolina. His postdoctoral training was completed at Case Western Reserve University, UC-Berkeley, UC-San Francisco and University of Florida. He has authored more than 200 articles, book chapters, and published abstracts. Dr. Odom’s research has been supported by grants from major foundations and governmental agencies, including the Knights Templar, Benedum Foundation, National Institutes of Health, the Department of Defense, the National Science Foundation, Center for Medicare and Medicaid Services, and the Social Security Administration. He was awarded the Francqui International Interuniversity Chair in 1996 by Belgium’s Franqui Foundation.  Dr. Odom holds four patents. Dr. Odom has served in a number of leadership roles within WVU and the WVU Eye Institute. He directed the Center for Vision Enhancement Technology and served as Director of Research at the WVU Eye Institute.  Dr. Odom is a past editor-in-chief of Documenta Ophthalmologica, has served an editor for special issues in Documenta Ophthalmologica, International Journal of Neuroscience, Journal of Visual Impairment Research, The Journal of Modern Optics, and Insight.  He is a former member of the Board of Directors of the International Society for Clinical Electrophysiology of Vision (ISCEV), and has chaired the ISCEV VEP Standardization Committee twice. He has served the Association for Vision and Ophthalmology on its program committee and on its long range planning committee. For his service to ARVO he was recognized as a Gold Fellow. He has served on the rotating committee of officers for the Low Vision Research Group’s. He serves regularly on national grant review panels related to Low Vision. He currently serves as a Board Member of the Smith-Kettlewell Eye Research Institute. Dr. Odom has also been active in promoting outreach services though the Appalachian Vision Outreach Project and the Lions Vision Clinic by the WVU Eye Institute.  He has served as the president of his local Lions Club and been the recipient of the WV Lions Sight Conservation Foundation’s Leonard Jarrett Award as recognition of his distinguished service for sight and hearing conservation.

Research: Assessment of visual function using electrophysiology and psychophysics in normal and abnormal vision Investigates higher order visual perception in older patients with low vision Optic flow as a means of controlling locomotion and navigation in patients with reduced visual abilities Strategies to assess quality of life in patients with reduced vision Development of strategies to noninvasively assess systemic diseases and toxic exposures.  

Dr. Gang Chen is Professor in Jiangsu Key Laboratory of Neuroregeneration at the University of Nantong, China. He received Ph.D. in Neuroregeneration from Nantong University, Jiangsu, China in 2008. He is the author of several publications. He serves as a reviewer for more than twelve journals. 

Research: Neuro-immune interactions in persistent pain Neuroinflammation and chronic pain Neuropathic pain and inflammatory Glial cells (microglia and astrocytes) in chronic pain Cytokines and chemokines in pain Spinal cord synaptic transmission and pain Nerve regeneration

Wei-Yen Hsu is a Professor of Information Engineering and Management, and Director of Healthcare Data Mining Center at National Chung Cheng University in Chiayi, Taiwan. He received the Ph.D. degree in the Department of Computer Science and Information Engineering, National Cheng Kung University, Tainan, Taiwan, in 2008. He received a Young Investigator Presidential Award at Taipei Medical University and National Cheng Kung University. He is a Founding Member of Brain-Computer Interface (BCI) Society.

Research: Neuroscience Methods Brain-Computer Interface Neurophysiology Neural Engineering Computational Neuroscience Non-linear Dynamics of Neural Systems Biomedical Engineering Medical Image Processing

Dr. Shengwen Calvin Li is a Principal Investigator (PI) and Faculty Scientist in Neuro-Oncology and Stem Cell Research Laboratory, CHOC Children’s Hospital Research Institute at the University of California-Irvine School of Medicine. He also serves as an Adjunct Faculty/Staff in the Department of Neurology, Beckman Laser Institute at the University of California-Irvine School of Medicine. Adjunct Professor at the Thomas Jefferson University Stem Cell Biology and Regenerative Medicine Center, Philadelphia, PA, USA; California State University Fullerton, CA, USA; Sun Yat-sen University, China. He has published over 148 publications including the peer-reviewed research articles, reviews, book chapters, and patent applications. He has served on the editorial board of several journals. He has also served on an ad-hoc reviewer for many other journals and grant agencies. He has been a member of Association for Clinical and Translational Science (ACTS), Society for Translational and Clinical Sciences, International Society for Stem Cell Research (ISSCR), Society for Neuroscience (SfN), American Society for Cell Biology (ASCB), American Association for the Advancement of Science (AAAS), American Society for Neurochemistry (ASN), and American Society of Investigative Pathology (ASIP).

Research: Pediatric Brain Tumor Biology Stem Cell Differentiation Mechanisms Stem Cell-Based Therapy Engineered Tissue Graft Engineer-Design Matrix for Cell and Organ Culture Caveolin-Mediated Signal Transduction Immunotherapy of Cancer Real-Time Imaging for Tumor Progression and Stem Cell Development Precision Medicine

Dominique M. Durand is E.L. Linsedth Professor of Biomedical Engineering and Neurosciences and Director of the Neural Engineering Center at Case Western Reserve University in Cleveland, Ohio, USA. He received an engineering degree from Ecole Nationale Superieure d'Electronique, Hydrolique, Informatique et Automatique de Toulouse, France in 1973. In 1974, he received a M.S. degree in Biomedical Engineering from Case Reserve University in Cleveland OH., worked several years at the Addiction Research Foundation of Toronto, Canada and in 1982 received a Ph.D. in Electrical Engineering from the University of Toronto in the Institute of Biomedical Engineering. He received an NSF Young Investigator Presidential Award as well as the Diekhoff and Wittke awards for graduate and undergraduate teaching and the Mortar board top-prof awards at Case Western Reserve University. He is an IEEE Fellow and also Fellow of the American Institute for Medical and Biomedical Engineering and Fellow of the Institute of Physics. He serves on fourteen editorial boards of peer-reviewed scientific journals and he is the editor-in-chief and founding editor of the Journal of Neural Engineering. He has obtained funding for his research from the National Science Foundation, the National Institutes of Health and private foundations. He has published over 120 peer-reviewed articles and he has consulted for many biotechnology companies and foundations.

Research: Epilepsy Neural Prostheses Applied Magnetic Neurophysiology Neural Engineering Computational Neuroscience Non-linear Dynamics of Neural Systems Electrical Field Interactions with Neural Tissue

Professor William J Winslade is currently working as a Professor in the department of Philosophy at Medicine Institute for the Medical Humanities and Department of Preventive Medicine and Community Health at University of Texas Medical Branch, USA. He received Ph. D in Philosophy and Psychoanalysis from Northwestern University, Evanston, Illinois and Southern California Psychoanalytic Institute, Los Angeles, California respectively. He received a law degree (JD) from Order of the Coif, UCLA School of Law, Los Angeles, California in 1972. He has extensive experience as an ethics consultant. He established and directed the UCLA a legal and ethical consultation service (1980-1984), and the ethical consultation service at UTMB (1985-1995). He has published articles on ethics consultation and co-authored a highly regarded textbook on clinical ethics. He served as an ethics consultant for state and federal agencies, national and international professional organisations, public and private, Healthcare institutions, health professionals, patients, law firms, attorneys and other individual clients. He serves as a member of Houston Bar Association, American Society of Bioethics and Humanities, UT System and other scientific societies. He won awards from so many universities. He serves as an editorial board member for several journals.

Research: Neuroethics Neurolaw Traumatic Brain Injury Privacy and confidentiality in the physician/patient relationship Legal and ethical issues in health care, especially terminal care Psychodynamics of medical practice Social and Legal Aspects of Traumatic Head Injury Organ Transplantation Law and Ethics of Health Policy Universal Access to Healthcare Prisoners as Patients: Ethics Education for Prison Health Professionals

Dr. David P. Richman is presently working as professor in the Department of Neurology and Center for Neuroscience at University of California, United States. He is an honorary Member of several Societies, Organizations, University Committees, and has received many honors and grants. He has numerous publications in peer reviewed journals. 

Research: Dr. David P. Richman's professional interests include biochemistry and pharmacology of the nicotinic acetylcholine receptor and muscle-specific kinase (MuSK), diseases of neuromuscular transmission, myasthenia gravis, anti-MuSK myastemia, and Lambert-Eaton myasthenic syndrome, and the pathogenesis and control of autoimmune response in myasthenia gravis. 

Dr. Huangui Xiong is currently working as Professor in the Department of Pharmacology and Experimental Neuroscience at University of Nebraska Medical Center, US. He has memberships in various professional organization’s and also acting as editorial board member for open access journal publications. He has authored a book, many book chapters and articles.    

Research: Dr. Huangui Xiong is a neuroelectrophysiologist working in the field of NeuroAIDS. Current research in his laboratory studies molecular and cellular mechanisms underlying HIV-1-associated cellular and synaptic dysfunction and injury, focusing on pathogenic roles played by voltage-gated potassium channels and NMDA receptors, in addition to his ultimate goal of identifying potential target(s) for the development of therapeutic strategies.

Dr. Lars Larsson is Professor of Department of Physiology and Pharmacology and Department of Clinical Neurophysiology at Karolinska Institutet, Sweden. He received MD and PhD degrees and a specialist degree in clinical neurophysiology from Karolinska University Hopsital, Sweden. He did his post-doctoral training at the Pennsylvania State University, Padova University and University of Wisconsin-Madison, USA. He has also held the position as the Marie Underhill Noll Professor at the Pennsylvania State University, Professor and Chair at Clinical Neurophysiology, Uppsala University Hospital. He is a primary and secondary mentor for the graduate and postdoctoral students. He has published over 200 peer-reviewed articles.

Research: Dr. Lars Larsson's research work has focused on the mechanisms underlying the impaired muscle function associated with aging and primary and secondary myopathies affecting sarcomeric proteins. He identified the first ICU patient with critical illness myopathy in Sweden 20 years ago and has since then studied the mechanisms underlying this acquired myopathy in clinical and experimental studies, developed sensitive diagnostic methods and introduced specific intervention strategies.

Frank Barone is an accomplished leader with significant experience as researcher and Professor in Drug Discovery and Academia. Frank has made significant contributions to discovering drugs, to increasing the understanding of drug action and to the biology of several diseases. His strong scientific, management and communication skills have been demonstrated consistently throughout his career. Frank has established a long-term track record of building functional, cohesive research teams that are empowered to meet and exceed their research goals. Specifics include: • 25 years in Drug Discovery functioning as research team leader in developing and executing research strategies from target discovery to drug screening and target validation in disease to marketed drug and post-market drug scientific support; History of maintained/consistent research/resource support in industrial environment for disease target research and compound progression in Discovery Research. • Significant experience as consultant to Pharmaceutical Companies, and in the academic work environment helping to developing research direction, helping to secure federal research grant support and teaching. • Ability to Integrate Systems Pharmacology/Biology and Translational Medicine into Drug Discovery and Disease Biology Research. • Long standing research background/experience in cardiovascular and cerebrovascular diseases. • Member of journal editorial boards and NIH study groups; scientific reviewer to many journals, granting organizations and study groups/sections; member of numerous scientific societies; four faculty appointments; currently have published over 200 scientific manuscripts, reviews, chapters and patents. 

Research: Basic scientific study of Cerebrovascular dieases with focus on ischemic stroke, vascular dementia and trauma; Development of animal disease models that can translate well to man and will facilitate our understanding of disease biology, pathology and signaling, and biomarkers in order to impact drug discovery and advances in therapeutic interventions; Persue close collaborations with Clinical Researchers and Neuroscientists to help make Translational Medicine a reality.

Research: Peripheral nervous system, particularly with respect to diagnosing neuropathies, treating neuropathic cellular mechanisms of drug actions, drug development, and brain cancers. 

Dr. Yuchuan Ding is presently working as a Professor and Associate Chair for Research at Wayne State University School of Medicine, USA. He had completed his postdoctoral fellowship at Vanderbilt University Medical School, USA in 1998. He had published many peer reviewed articles and has Professional Memberships in several organisations.

Research: Dr. Yuchuan Ding’s research Interests includes Ischemia/Reperfusion Injury; Stroke Therapy, Brain Metabolism, Blood-Brain-Barrier, Apoptosis, Exercise, Preconditioning and Neuroprotection

Professor Crewther began her studies at Melbourne University then moved to the US to complete her PhD in Neuroscience at Caltech under Nobel Prize Winner Professor Roger Sperry.  Sheila has professional qualifications in Neuropsychology, Education and Optometry and these underlie her research into the cognitive and behavioural neuroscience of neuroplasticity in neurodevelopmental and neurodegenerative anomalies. The aim is to use this knowledge to design better behavioural and therapeutic management regimes.  Professor Crewther led the Victorian Government Department of Human Services Review and Report ‘Prevalence and services for children 0-6 years of age with ‘Autism Spectrum Disorders in 2002 -2003.   This has resulted in substantially increased funding and the initiation of the first state government general assessment plan for those with autism and their families in Australia.  She has also led the research that initiated increased Australian optometric focus (2004-2010) on the role of children’s functional vision in reading and learning and in Intellectual Disability.

Research: Cognitive Neuroscience Behavioural and Molecular Neuroscience

Research: Neurobiology of aggression and rage Behavioral neuropharmacology Neuroanatomy Limbic system and behavior

Research: Dr. Walter J. Lukiw had a long-standing professional interest in human brain and retinal gene expression and its regulation, as it pertains to memory, cognition, aging and to neurological disorders, particularly Alzheimer’s disease (AD), and age-related macular degeneration (AMD), in small RNAs and messenger RNAs in the brain and retina, in IL-1β- TNFα- and Aβ42-related signaling functions in inflammation and inflammasome-mediated disease mechanisms, and in neurodegenerative diseases are associated with glial cell proliferation.

Dr. Hongbin Fang is now an Associate Professor in Georgetown University Medical Center. Before joined Georgetown University in 2013, he was Associate Professor of Biostatistics at the University of Maryland Greenebaum Cancer Center and the Department of Epidemiology and Public Health at the University of Maryland School of Medicine. He received his Ph.D. degree from Hong Kong Baptist University in 1998. Dr. Fang conducted postdoctoral research in biostatistics at the University of Missouri-Columbia and St. Jude Children’s Research Hospital.

Research: Clinical trials Systems biology Survival analysis Multivariate analysis Theory of distributions in statistics Longitudinal and functional data analysis Experimental design and statistical analysis in drug development  

Research: Phase 2 and Phase 3 clinical drug trials in Amyotrophic Lateral Sclerosis

Dr. Wayne Brake was hired as an Assistant Professor in Psychology in 2005. Prior to joining Concordia University, he was an Assistant Professor at the University of California Santa Barbara. Dr. Brake earned his Ph.D. in Neurological Sciences at McGill University and completed post-doctoral studies in Neuroendocrinology at The Rockefeller University in New York. Dr. Brake is the Director of the MA Graduate Program in Psychology as well as a Fellow of the Science College at Concordia University. Globally, Dr. Brake’s research addresses women’s health in the context of how hormonal status affects brain function and behavior. His NSERC funded research program examines the effects of the female ovarian hormone, estrogen, on brain dopamine physiology and learning and memory. This work has generated several important findings that have gained extensive interest from the press worldwide. A second line of research examines the critical link between ovarian hormones and the brain’s response to antipsychotic medication. Dr. Brake has active, ongoing collaborations with colleagues locally at the Center for Studies in Behavioral Neurobiology as well as national and international collaborations including researchers at Cornell Medical School in the USA. In addition, he is a member of the editorial board of the international journal, Advances in Endocrinology.

Research: The mechanisms by which the early environment in rodent models affects development of brain function and behavior. His lab investigates how birth complications and early maternal-infant relationships affect brain development; specifically the dopamine system. These studies are carried out to understand the mechanisms underlying disorders such as attention deficit-hyperactivity disorder (ADHD) and schizophrenia as well as why, upon adulthood, some are more susceptible to the ill-effects of repeated stress and the incentive values of drugs of abuse. Another line of research examines how ovarian steroids (e.g. estrogen) affect plasticity of the brain and subsequent behavior. Dr. Brake's lab employs behavioral tests, modern anatomical techniques and cutting edge methods to measure changes in neurochemistry to ultimately understand how our early environment and hormonal milieu shape our adult life.

Dr. James Tao obtained his MD degree in Wannan Medical College in Wuhu city, China in 1984. After his graduation, he went to Capital Medical University in Beijing, China for a post-graduate study. In 1997, he obtained his PhD degree in neuroscience at the University of Cincinnati, Cincinnati, OH. In 2001, Dr. Tao completed his neurology residency training in the Department of Neurology at the University of Chicago, and then completed his training as a clinical neurophysiology/epilepsy fellowship in 2002 in the same department. He became a faculty in the Department of Neurology at the University of Chicago in the same year. Currently he is an associated professor of Neurology. Dr. Tao specializes in the diagnosis and management of seizure disorders and epilepsy syndromes. Dr. Tao is interested in the use of anti-epileptic drugs (AEDs), surgery and neuro-stimulation for treating patients with medically resistant epilepsy.

Research: Dr. Tao’s research focuses on the use of electrophysiology and neuroimaging, including computed tomography (CT), magnetic resonance imaging (MRI), and positron emission tomography (PET) to precisely localize the epileptic focus and subsequently to guide epilepsy surgery. In addition, Dr. Tao is interested in the mechanism and prevention of sudden unexpected death in epilepsy (SUDEP), which is the leading cause of mortality in patients with chronic uncontrolled epilepsy.

Dr. Tatjana Rundek is a Professor of Neurology, Epidemiology and Public Health with tenure, Vice Chair of Clinical Research, and a Director of Clinical Translational Research Division in the Department of Neurology of the University of Miami Miller School of Medicine. She holds a secondary faculty appointment at the Department of Neurology at Columbia University in New York. Dr. Rundek is a stroke neurologist, clinical researcher and principal investigator of several NIH/NINDS funded R01 grants on genetic determinants of carotid atherosclerosis and stroke. Dr. Rundek is a recipient of a NINDS K24 mid career development award. She participates in large stroke genetic consortia including the NINDS Stroke Genetic Network and International Stroke Genetic Consortium. Dr. Rundek was the Fulbright Scholar and the recipient of the research awards from the Hazel K. Goddess and the Dr. Gilbert Baum Funds. Dr. Rundek serves on the editorial boards of several scientific journals, including Stroke, Neurology, Journal of Ultrasound in Medicine and Cerebrovascular Diseases. She has published over 210 scientific publications, editorials, reviews, and book chapters. She is a fellow of the American Neurological Association, a member of the American Heart Association and American Academy of Neurology. She is past President of the Neurosonology Communities of Practice of the American Institute in Ultrasound in Medicine, the largest professional medical ultrasound organization in the US. Dr. Rundek serves on the Intersocietal Accreditation Commission (IAC) Vascular Testing Board of Directors, a national organization that accredits clinical echocardiography, nuclear/PET, MRI, CT and Dental laboratories and carotid stenting programs.

Research: Stroke prevention and outcome Neuroimaging Epidemiology Neurosonology, carotid ultrasound, TCD Subclinical atherosclerosis Stroke and CVD in women

Dr. Yan Zhou is currently working as an Associate Professor in the Department of Pharmacology at Guangxi Medical University, Nanning, China. She accomplished her MD training in Tongji Medical University, earned her PhD at Guangxi Medical University and did her postdoctoral trainings at University of Minnesota and University of Nebraska Medical Center. She has memberships in National and International professional societies and serves as an ad hoc reviewer for several academic Journals. 

Research: Dr. Yan Zhou is an electrophysiologist working in the field of Neuroscience. Her laboratory studies cellular and molecular mechanisms underlying HIV-associated neurodegeneration, focusing on the interaction of chemokines and NMDA receptors. Also studied in her laboratory is the investigation of neuroprotective effects of Chinese herbal extracts, in particular, panax notoginseng saponins.

Professor WK Tang was appointed to professor in the Department of Psychiatry, the Chinese University of Hong Kong in 2011. Professor Tang completed his medical training at the Chinese University of Hong Kong. He joined the Chinese University of Hong Kong as an academic staff since 1999. His main research area is Neuropsychiatry in Stroke. Professor Tang has published over 100 papers in renowned journals, and has also contributed to the peer review of 40 journals. He has secured over 20 major competitive research grants. He has served the editorial boards of five scientific journals. He was also a recipient of the Young Researcher Award in 2007, awarded by the Chinese University of Hong Kong.

Research: Neuropsychiatry in Stroke

Dr. Sullivan is an Assistant Professor at the University of South Florida in the College of Medicine, Department of Neurology and College of Public Health, Department of Epidemiology and Biostatistics. She obtained her PhD in epidemiology from the University of South Florida with an emphasis in neuroepidemiology. 

Research: Risk factors for neurologic conditions and evaluation of potential new treatments for these conditions as well as design, management and analysis of studies for conditions including tremor, Parkinson’s disease, and ataxia.

Dr. Alok Dabi is currently working as an Assistant Professor in the Department of Neurology and Neurosurgery and Director of the Neurosciences Critical Care program at University of Texas Medical Branch (UTMB) in USA. He received a degree in Bachelor of Medicine and Bachelor of Surgery from Sawai Man Singh Medical College, Jaipur, Rajasthan, India in 1999. He was instrumental in the growth of the Neurocritical Care Unit to 14 beds from the initial 8 beds. He received awards and certifications in the field of neurology from various universities. He is actively involved with teaching activities involving the Neurocritical Care Unit (NCCU) staff, besides being an active member of various institutional committees, including the Organ Donation Committee, Anticoagulation Committee and Multidisciplinary Critical Care Committee. He has been an invited speaker on different critical care topics including Targeted Temperature Management, Aphasia and Language disorders etc. He has published peer-reviewed articles in international standard journals.

Research: Neuroprotection Targeted Temperature Management Brain-Gut-Axis and its role in the Neurological Disorders Neuroprotective management strategies in Acute Stroke Pharmacological Neuroprotection in Critically-ill Neurological patients

Dr. Liu earned a doctorate in rehabilitation science from the University of Maryland and a masters in biomedical engineering from University of Vermont. Liu holds faculty position at school Kinesiology, Auburn University. He is director of Rehabilitation Biomechanics Laboratory (RBL) at Auburn University. Dr. Liu is a rehabilitation scientist specializing in biomechanics and motor control. He has extensive research experience of motion analysis of lower and upper extremities function movement such as arm reaching and human walking. Dr. Liu’s current research is focusing on combining aspects of Motor Control Theory, Biomechanics Modeling approach and Imaging technique such as Electroencephalogram (EEG), f-MRI to develop improved treatment interventions for individuals with disability such as Stroke.

Dr Glen Jickling is an Assistant Professor at the University of California Davis, in the Department of Neurology.  His research interests are the genomics and genetics of cerebrovascular disorders.  He obtained his MD from the University of Alberta and Masters in applied science at UC Davis.  He completed his Neurology residency at the University of Alberta, and a Stroke fellowship at UC Davis. 

Research: RNA as markers of cerebrovascular disease miRNA regulation of RNA in stroke Immune response in stroke

Dr Dave was born and grew up in Mumbai, India. He received his Ph.D. degree from University of Mumbai in 1998. Dr. Dave for his postdoctoral training in molecular virology at Columbia University and subsequently continued his training in neuroAIDS and molecular virology at Thomas Jefferson University. Dr Dave joined the Center for neuroAIDS Research in the Department of Neuroscience in 2008 where his research is focused on elucidating role of miRNAs in HIV-induced brain diseases in opiate-abusers.

Research: His interest is focused on investigating the role of small non-coding RNAs, in HIV-1 neuropathogenesis. Small non-coding RNAs, such as microRNAs (miRNAs) and small interfering RNAs (siRNAs) possess the ability to regulate gene expression through post-transcriptional gene silencing mechanisms. Both miRNAs and siRNAs have an integral role in disease etiology and host-virus interactions. Alterations in miRNA expression often correlate with onset of cancers, viral infections or mental disorders. Several human viruses also express miRNAs. HIV-1 infection of the Central Nervous System (CNS) often leads to HIV-1-associated dementia (HAD) and HIV-1-associated minor cognitive motor disorder (HMCMD). HIV-1 infection is associated with macrophage infiltration, formation of microglial nodules and multinucleated giant cells, astrocyte activation and neuronal loss. Perivascular macrophages and microglia present in the hippocampus and basal ganglia are predominantly infected. However, the role of miRNAs and siRNAs in HIV-1 infection of CNS remains unclear. Currently, we are investigating alterations in miRNA expression profiles and how they might affect the course of disease progression in HIV-1-infected opiate abusers. This cohort is of interest as it often exhibits an accelerated form of HIV-1 associated dementia and enhanced neurological dysfunction.

He is a (Italian) board certified radiologist with an extensive training in neuroradiology. He is performing clinically orientated research in the field of motor neuron disease focusing on understanding the relationship between disorders of the motor neuron disease spectrum and imaging markers of disease progression. Assessing whether imaging measures are reliable biomarkers of progression requires skills in measuring clinical function and quantitative imaging. His training in neuroradiology and experience in processing and analysis of advanced MRI techniques provided him with the background and expertise needed to carry out this research program. Over the past 6 years, He has carried out neuroimaging studies of pediatric and adult neurological disorders, acquiring expertise in quantitative methods of analysis in particular diffusion tensor imaging (DTI), and susceptibility weighted imaging (SWI).

Research: 1.Analysis of structural and functional magnetic resonance imaging biomarkers  and the correlation between neuroimaging measures and measures of disease progression in patients with upper motor neuron forms of motor neuron disease. 2. Diffusion tensor imaging of the spinal cord 3. Application of DTI in congenital malformations of the CNS 4. Stroke imaging 5. Application of susceptibility weighted imaging in the study of neurodegenerative diseases.